BioMap Unveils New Zhichun Road Office in Beijing, Elevating Its Global R&D Footprint
BioMap
Developer of Innovative Drug R&D Platform
Return to the "Large Model Concentration Area," Deeply Rooted in the Core Zone of Zhongguancun
BioMap Opens New Office Space in Zhichun Road, Beijing in October
Global R&D Layout: Synergistic Development of Four Innovative Cities
In conjunction with the company's business development, we have recently completed a systematic upgrade of our global R&D layout — establishing various R&D institutions in four innovative cities with unique advantages. Each institution has its own focus, working collaboratively to advance the projection of large foundational models in life sciences into more application areas, creating additional task-specific AI models, and empowering the success of customers in drug discovery, biomanufacturing, healthcare, and other fields.
Beijing
AI Core Technology R&D Center,
Focus on large model algorithms and technological innovation
Suzhou
Biological Experiment and Data Research & Development Center,
Gathering advanced laboratory facilities and data acquisition capabilities
Palo Alto
AI Protein Design Dry-Wet Closed-Loop R&D Center,
Advance the Frontier Technology of Protein Design
Hong Kong
International Innovation Center,Global Innovation CooperationConnection Hub，
Promote the Implementation and Development of International Projects
Thank you for the support and trust from customers and partners.
In the future, we will continue to uphold the spirit of a challenger, working hand in hand with more industry partners towards AI transformation. We look forward to the upcoming October 27th.The 3rd BioMap Conference(Click to view the conference agenda), and gather with everyone once again to jointly witness the innovative integration of life sciences and AI technology!
